Results for tag: "Istodax"

Istodax (romidepsin) is a drug used to treat cutaneous and peripheral T-cell lymphomas (CTCL and PTCL). It is a histone deacetylase inhibitor, which works by blocking the activity of an enzyme that helps cancer cells grow and divide. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of CTCL and PTCL in adults who have received at least one prior systemic therapy. Istodax is marketed by Celgene Corporation, a biopharmaceutical company based in the United States. The drug is also available in other countries, including Canada, Australia, and the European Union. The Istodax market is highly competitive, with several companies offering similar drugs for the treatment of lymphoma. These include Bristol-Myers Squibb, Merck, Pfizer, and Novartis. Other companies in the market include GlaxoSmithKline, AstraZeneca, and Johnson & Johnson. Show Less Read more